0 NASDAQ Companies - September 4, 2019Orchard Therapeutics Announces Encouraging Update from Proof-of-Concept Study of OTL-203 for the Treatment of Mucopolysaccharidosis Type I (MPS-I)Read More
0 Canadian Stock Exchange News - September 4, 2019LiteLink Technologies Provides Corporate UpdateRead More
0 Canadian Stock Exchange News - September 4, 2019XORTX Highlights New Research on Polycystic Kidney Disease Awareness DayRead More
0 NYSE Companies - September 4, 2019GasLog Ltd. Signs 10-Year Time Charter For Provision Of An LNG Floating Storage Unit To Panama Power ProjectRead More
0 NASDAQ Companies - September 4, 2019Anavex Life Sciences Announces Initiation of the EXCELLENCE ANAVEX®2-73-RS-003 Clinical Study in Pediatric Patients with Rett SyndromeRead More
0 NASDAQ Companies - September 4, 2019Applied Therapeutics Announces Initiation of Phase 3 Registrational Trial of AT-001 in Diabetic Cardiomyopathy (ARISE-HF)Read More
0 NASDAQ Companies - September 4, 2019Mimi Hearing Technologies Teams Up With DSP Group to Optimize Speech Intelligibility in the Voice Enterprise FamilyRead More
0 NASDAQ Companies - September 4, 2019AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging AgentRead More
0 NASDAQ Companies - September 4, 2019Athenex Announces Appointment of Daniel Lang MD to Lead TCR-T Immunotherapy Operations and Support Corporate Development StrategyRead More
0 NASDAQ Companies - September 4, 2019Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2019Read More
